Advertisement
UK markets close in 4 hours 46 minutes

  • FTSE 100

    8,211.76
    +39.61 (+0.48%)
     

  • FTSE 250

    20,067.88
    +15.55 (+0.08%)
     

  • AIM

    770.16
    +2.05 (+0.27%)
     

  • GBP/EUR

    1.1687
    +0.0005 (+0.04%)
     

  • GBP/USD

    1.2553
    +0.0020 (+0.16%)
     

  • Bitcoin GBP

    47,017.17
    +1,063.87 (+2.32%)
     

  • CMC Crypto 200

    1,284.26
    +7.28 (+0.57%)
     

  • S&P 500

    5,064.20
    +45.81 (+0.91%)
     

  • DOW

    38,225.66
    +322.37 (+0.85%)
     

  • CRUDE OIL

    79.04
    +0.09 (+0.11%)
     

  • GOLD FUTURES

    2,308.60
    -1.00 (-0.04%)
     

  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     

  • HANG SENG

    18,475.92
    +268.79 (+1.48%)
     

  • DAX

    17,994.17
    +97.67 (+0.55%)
     

  • CAC 40

    7,962.35
    +47.70 (+0.60%)
     
PROPERTY:

11 fabulous farmhouses perfect for living a rural lifestyle

A farmhouse could be your dream home if you’re in search of bucolic bliss

Baxalta executive says will not do defensive M&A

Reuters - UK Focus

NEW YORK, Sept 16 (Reuters) - A top executive at Baxalta Inc , which was approached with a takeover offer from Shire (Amsterdam: QB8.AS - news) PLC, said on Wednesday the company did not plan to rush into doing a defensive deal to try to fend off its unwanted suitor.

Chief Financial Officer Bob Hombach said during a presentation webcast from the Morgan Stanley Global Healthcare conference that the company was still interested in doing deals that made sense, but that it would not change its strategy "just because somebody knocked on our door on day 1."

Shire (Xetra: S7E.DE - news) approached Baxalta (Berlin: 9BX.BE - news) shortly after it was spun off from Baxter International (NYSE: BAX - news) into a standalone public company. Baxalta has so far rejected the offer.

Baxalta shares closed up 1 cent at $37.07 on the New York Stock Exchange. (Reporting by Caroline Humer; Editing by Meredith Mazzilli)